Upgrade to SI Premium - Free Trial

Metagenomi (MGX)

1.21 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26 *Est.)

Latest Headlines

Metagenomi Inc (MGX) PT Lowered to $7 at Wells Fargo August 11, 2026 6:56 AM - StreetInsider Metagenomi, Inc. (MGX) Tops Q2 EPS by 5c August 10, 2026 6:23 PM - StreetInsider Form 10-Q Metagenomi Therapeutics, For: Jun 30 August 10, 2026 4:13 PM - SEC Filing Form 8-K Metagenomi Therapeutics, For: Aug 10 August 10, 2026 4:11 PM - SEC Filing Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results August 10, 2026 4:05 PM - StreetInsider Prolynx names CFO and CSO to advance obesity drug portfolio July 15, 2026 8:01 AM - StreetInsider Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio July 15, 2026 8:00 AM - Globe NewsWire Chardan Starts Metagenomi Inc (MGX) at Buy July 7, 2026 6:37 AM - StreetInsider Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: Reid Laurence June 11, 2026 2:32 PM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: Dere Willard H June 11, 2026 2:23 PM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: BJERKHOLT ERIC June 11, 2026 1:49 PM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: Eckhardt Juergen June 11, 2026 1:38 PM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 05 Filed by: Wapnick Pamela June 10, 2026 11:24 AM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 05 Filed by: Irish Jian June 10, 2026 11:22 AM - SEC Filing Form 4 Metagenomi Therapeutics, For: Jun 05 Filed by: Wein Matthew June 10, 2026 11:20 AM - SEC Filing Form 8-K Metagenomi Therapeutics, For: Jun 09 June 10, 2026 6:02 AM - SEC Filing Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference May 28, 2026 8:00 AM - StreetInsider Full Article List